{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:40:16Z","timestamp":1792626016504,"version":"4.5.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajpc.2026.101677","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:37:25Z","timestamp":1779320245000},"page":"101677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond traditional risk scores: Proteomic prediction of heart failure in MASLD"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-8146","authenticated-orcid":false,"given":"Jessica A.","family":"Regan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2026.101677_bib0001","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpc.2026.101677_bib0002","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.3567","article-title":"Metabolic dysfunction-associated steatotic liver disease is associated with increased risks of heart failure","volume":"27","author":"Chang","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ajpc.2026.101677_bib0003","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jchf.2024.09.022","article-title":"Clinical and proteomic risk profiles of new-onset heart failure in men and women","volume":"13","author":"Qin","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ajpc.2026.101677_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2026.101662","article-title":"Large-scale plasma proteomics improves prediction of heart failure among MASLD individuals: a prospective cohort study","author":"Xiong","year":"2026","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2026.101677_bib0005","doi-asserted-by":"crossref","first-page":"710","DOI":"10.14309\/ajg.0000000000003595","article-title":"Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction-associated steatotic liver disease","volume":"121","author":"Barritt","year":"2026","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajpc.2026.101677_bib0006","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ajpc.2026.101677_bib0007","doi-asserted-by":"crossref","DOI":"10.1097\/CRD.0000000000001298","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular disease: shared mechanisms and therapeutic opportunities","author":"Basta","year":"2026","journal-title":"Cardiol Rev"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:08:59Z","timestamp":1792624139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726002527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":7,"alternative-id":["S2666667726002527"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101677","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond traditional risk scores: Proteomic prediction of heart failure in MASLD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101677"}}